Skip to main content
. 2022 Oct 29;40(1):4. doi: 10.1007/s12032-022-01790-0

Table 2.

Chemotherapy regimens administered to patients with locoregional recurrence

Study reference Chemotherapy regimens reported
Brooks et al. [23]

Platinum/paclitaxel

Platinum/pemetrexed

Platinum/etoposide

Platinum/gemcitabine

Pemetrexed alone

Paclitaxel alone

IL-10

Pembrolizumab

Erlotinib

Friedes et al. [22]

Platinum-based sensitising

Platinum-based double/ single agent

Terada et al. [14]

Cisplatin/S-1

Cisplatin/vinorelbine

Carboplatin/paclitaxel

Lee et al. [15]

Cisplatin/paclitaxel

Cisplatin/docetaxel

Cisplatin/etoposide

Carboplatin/paclitaxel